Voor de beste ervaring schakelt u JavaScript in en gebruikt u een moderne browser!
Master Biomedical Sciences: Medical Biology tracks

Oncology

Biomedical Sciences (MSc)

Introduction

Cancer is a major health problem in modern-day society and is one that demands the attention of the scientific community. The Master's programme in Oncology provides training for biomedical life science students to become qualified researchers, capable of making distinctive contributions to the improved diagnosis and treatment of cancer in the near future.
 

Studying Oncology at the University of Amsterdam

The Academic Medical Centre and the Netherlands Cancer Institute (NKI) have collaborated with the University of Amsterdam (UvA) to create a Master's programme that offers students a comprehensive introduction to contemporary cancer research.

Programme Outline

The Master's programme in Oncology covers topics such as basic cell and molecular biology, genetics, development of novel strategies for cancer diagnosis and treatment, proof of principle as well as studies in model systems and clinical trials. Students acquire practical experience by conducting research in laboratories and gain a sound theoretical background through a combination of regular group meetings with qualified researchers and courses taught by leading scientists in the field. The ultimate objective for students in this programme is to translate basic science into clinical practice.

For detailed information regarding the curriculum and courses, check the UvA Course Catalogue

Is Oncology the track for me?

The programme is looking for students who:

  • are interested in the molecular basis of cancer development and in learning how to identify aberrant molecules that drive this process.
  • are fascinated by biological processes and enjoy doing laboratory work on the molecular and cellular level.
  • are able to contemplate new experimental approaches and ask the right questions.
  • have the ability to quickly absorb and integrate novel concepts
  • have a feeling for biological variability
  • are eager to work with two top institutes in the world of cancer research, the AMC and NKI